Satellos Bioscien…
CACADSatellos Bioscience Inc. (TO:MSCL) — Biotechnology: Pharmaceutical Preparations. Broj burzi na kojima se trguje dionicama tvrtke: 2. Na ovoj stranici — cijena i grafikon, dividende, najveći dioničari i povijest broja dionica.
O Tvrtki
- Web-Stranica
- satellos.com
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Sjedište
- MARKHAM, Canada
- Glavni Direktor
- Francis Gleeson
- Zaposlenici
- 18
- Dionice u Optjecaju
- 21.22 mil.
- Slobodno Prenosive Dionice
- 18.02 mil.
- Tržišna Kapitalizacija
- 207.71 mil. CAD
- Insajderi
- 6.37%
- Institucionalni Ulagači
- 49.7%
- Djelatnost (SIC)
- Pharmaceutical Preparations
- P/E
- gubitak
- FCF
- −23.6 mil. USD
- Dug
- ?
- Zarada i FCF — za 12 mjeseci do 31.12.2025 (najnovije izvješće tvrtke).
Opis
Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. The company uses its proprietary discovery platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247, an oral, small molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.
Najveći Imatelji
| Imatelj | Udio | Dionice | Datum Izvješća |
|---|---|---|---|
| Franklin Resources, Inc. | 4.42% | 938 666 | 2026-06-30 |
| Siren, L.L.C. | 4.2% | 892 074 | 2026-06-30 |
| Vivo Capital, LLC | 3.84% | 813 666 | 2026-06-30 |
| Berger (Franklin Milan)… | ≈3.25% | 688 258 | 2026-07-14 |
| Point72 Asset Management… | 3.22% | 682 700 | 2026-06-30 |
| Sphera Funds Management… | 3.08% | 652 590 | 2026-06-30 |
| Woodline Partners LP | 2.36% | 500 432 | 2026-06-30 |
| Stonepine Capital Manage… | 2.32% | 491 624 | 2026-06-30 |
| Montanova Capital LLC | 2.24% | 475 000 | 2026-06-30 |
| Avidity Partners Managem… | 1.83% | 387 769 | 2026-06-30 |
| Saturn V Capital Managem… | 1.65% | 350 000 | 2026-06-30 |
| Franklin Strategic Serie… | 1.62% | 343 237 | 2026-07-31 |
| Gleeson (Francis Michael… | ≈1.27% | 269 851 | 2026-01-30 |
| Rudnicki (Michael Anthon… | ≈1.22% | 258 159 | 2026-01-30 |
| Bloom (Brian Matthew) (D… | ≈0.32% | 67 233 | 2026-01-30 |
| MacKay (Geoffrey Ross) (… | ≈0.1% | 21 201 | 2026-01-30 |
| Fidelity Concord Street… | 0.06% | 13 021 | 2026-08-31 |
| Williams (Elizabeth) (Se… | ≈0.02% | 3 333 | 2026-01-30 |
| Nawacki (Mark Henry CPA)… | — | — | 2026-06-18 |
Prijavite se s Google